miR-221 regulates CD44 in hepatocellular carcinoma through the PI3K-AKT-mTOR pathway

Kim, J; Jiang, JM; Badawi, M; Schmittgen, TD

Schmittgen, TD (reprint author), Univ Florida, Coll Pharm, Gainesville, FL 32608 USA.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017; 487 (3): 709